Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 2140275
PUBLISHER: BCC Research | PRODUCT CODE: 2140275
Global Organoids and Spheroids Market
PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The report examines the global organoids and spheroids market, covering key trends, challenges, and market developments. It provides market estimates through 2031 and analyzes the market by product type, application, end user, and region. The study also looks at the use of organoids and spheroids in drug discovery, personalized medicine, disease studies, toxicity testing, developmental biology, and regenerative medicine. It covers major end users, including pharmaceutical and biotechnology companies, research institutes, CROs, hospitals, and diagnostic centers, along with the competitive landscape, market shares, and rankings of key businesses.
Report Scope
This report provides an overview of the global organoids and spheroids market by analyzing its trends. The market is defined as the revenue generated by companies that derive their revenue from the sale of products and technologies used to develop organoids and spheroids, as well as companies that develop, grow, and commercialize organoid and spheroid models.
The report includes global revenue ($ millions), with 2025 as the base year, estimates for 2026, and forecasts through 2031. The market is segmented by product type, application, end user, and region. Based on product type, the market is categorized into organoid and spheroid. Based on applications, the market is segregated into drug discovery and personalized medicine, developmental biology, disease pathology studies, drug toxicity and efficacy testing, and regenerative medicine. The regions covered in this study are North America, Europe, Asia-Pacific, South America, and the Middle East and Africa, with a focus on major countries in each region.
The report focuses on the significant trends and challenges that affect the market and vendor landscape. The market analysis covers the adoption of organoids and spheroids by various end users, including pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, hospitals and diagnostic centers, and other end users.
The report concludes with an analysis of the competitive landscape, which provides rankings and market shares for key businesses in the global organoids and spheroids market.
Report Includes
- Overview of the global organoids and spheroids market, highlighting the growing use of advanced 3D cell culture models in biomedical research, drug development, and precision medicine
- Revenue analysis for the base year 2025, together with market estimates for 2026 and forecasts through 2031 across major regional markets
- Breakdown of the market by type, application, end user, and region
- Discussion of the major growth drivers, restraints, and emerging opportunities influencing the adoption of organoid and spheroid technologies worldwide
- Insights into technological advancements, including innovations in spheroid technologies, CRISPR integration, bioprinting, and patent activity supporting next-generation research models
- Regional assessment of North America, Europe, Asia-Pacific, South America, and the Middle East & Africa, with country-level analysis of leading markets
- Competitive landscape review featuring market share analysis, company rankings, and strategic initiatives undertaken by established companies and emerging innovators
- Profiles of leading market companies, highlighting their business overview, product offerings, and recent developments
Product Code: BIO280A
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Market Dynamics and Growth Factors
- Emerging Technologies
- Segmental Analysis
- Regional Analysis
- Conclusion
Chapter 2 Market Overview
- Market Definition
- Organoids and Spheroids Overview
- Organoids Versus Spheroids
- Future Directions in Organoids and Spheroids Market
- Porter's Five Forces Analysis
- Threat of New Entrants (Moderate)
- Bargaining Power of Suppliers (Moderate to High)
- Bargaining Power of Buyers (Moderate)
- Threat of Substitutes (Moderate)
- Level of Competitiveness (High)
- Macroeconomic Factors Analysis
- Demographic Trends and Disease Burden
- Government Funding and Research Investments
- Healthcare Expenditure and Economic Growth
- Regulatory and Ethical Evolution
- Impact of U.S.-Iran Conflict on the Organoids and Spheroids Market
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Increasing Adoption of 3D Cell Culture Models Over Conventional 2D Cell Cultures
- Shift Toward Human-Relevant Alternatives to Animal Testing in Preclinical Research
- Rising Adoption of Organoids and Spheroids in Oncology Drug Discovery
- Market Restraints
- High Costs of Advanced 3D Cell Culture Systems
- Lack of Standardized Protocols and Quality Control
- Reproducibility Challenges
- Market Opportunities
- Expansion of Personalized Medicine and Precision Oncology
- Growing Applications of Organoids in Regenerative Medicine and Tissue Engineering
- Emergence of Automated High-Throughput Organoid Platforms
Chapter 4 Regulatory Landscape
- Overview
- Regulations and Standards by Country or Region
Chapter 5 Emerging Technologies and Patent Analysis
- Overview
- Emerging Technologies
- Advances in 3D Spheroid Engineering Technologies
- Integration of CRISPR and Genome Editing with Organoid Models
- Emergence of 3D Bioprinting for Complex Organoid Assembly
- Patent Analysis
- By Year
- By Jurisdiction
Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Market Analysis by Product Type
- Key Takeaways
- Organoids
- Spheroids
- Market Analysis by Application
- Key Takeaways
- Drug Discovery and Personalized Medicine
- Developmental Biology
- Disease Pathology Studies
- Drug Toxicity and Efficacy Testing
- Regenerative Medicine
- Market Analysis by End User
- Key Takeaways
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
- Hospitals and Diagnostic Centers
- Other End Users
- Geographic Breakdown
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- South America
- Middle East and Africa
Chapter 7 Competitive Intelligence
- Key Takeaways
- Competitive Landscape
- Strategic Analysis
Chapter 8 Appendix
- Research Methodology
- References
- Abbreviations
- Company Profiles
- BIO-TECHNE
- CORNING INC.
- GREINER BIO-ONE INTERNATIONAL GMBH
- INSPHERO
- LONZA
- MERCK KGAA
- MOLECULAR DEVICES LLC.
- REVVITY
- STEMCELL TECHNOLOGIES
- THERMO FISHER SCIENTIFIC INC.
- A Few Emerging Startups/Market Disruptors
Product Code: BIO280A
List of Tables
- Summary Table : Global Market for Organoids and Spheroids, by Region, Through 2031
- Table 1 : Difference between Organoids and Spheroids
- Table 2 : Porter's Five Forces: Rating Scale
- Table 3 : Estimated Cancer Incidence Cases, by Region, 2022-2045
- Table 4 : Estimated Cancer Incidence Cases in Males in the U.S., by Cancer Site, 2025
- Table 5 : Estimated Cancer Incidence Cases in Females in the U.S., by Cancer Site, 2025
- Table 6 : Regulatory Landscape Governing Organoids and Spheroids Solutions, by Country or Region
- Table 7 : Number of Patents, by Jurisdiction, 2024-2025
- Table 8 : Global Market for Organoids and Spheroids, by Product Type, Through 2031
- Table 9 : Global Market for Organoids, by Region, Through 2031
- Table 10 : Global Market for Spheroids, by Region, Through 2031
- Table 11 : Global Market for Organoids and Spheroids, by Application, Through 2031
- Table 12 : Global Market for Organoids and Spheroids for Drug Discovery and Personalized Medicine, by Region, Through 2031
- Table 13 : Global Market for Organoids and Spheroids for Developmental Biology, by Region, Through 2031
- Table 14 : Global Market for Organoids and Spheroids for Disease Pathology Studies, by Region, Through 2031
- Table 15 : Global Market for Organoids and Spheroids for Drug Toxicity and Efficacy Testing, by Region, Through 2031
- Table 16 : Global Market for Organoids and Spheroids for Regenerative Medicine, by Region, Through 2031
- Table 17 : Global Market for Organoids and Spheroids, by End User, Through 2031
- Table 18 : Global Market for Organoids and Spheroids for Pharmaceutical and Biotechnology Companies, by Region, Through 2031
- Table 19 : Global Market for Organoids and Spheroids for Academic and Research Institutes, by Region, Through 2031
- Table 20 : Global Market for Organoids and Spheroids for Contract Research Organizations, by Region, Through 2031
- Table 21 : Global Market for Organoids and Spheroids for Hospitals and Diagnostic Centers, by Region, Through 2031
- Table 22 : Global Market for Organoids and Spheroids for Other End Users, by Region, Through 2031
- Table 23 : Global Market for Organoids and Spheroids, by Region, Through 2031
- Table 24 : North American Market for Organoids and Spheroids, by Country, Through 2031
- Table 25 : North American Market for Organoids and Spheroids, by Product Type, Through 2031
- Table 26 : North American Market for Organoids and Spheroids, by Application, Through 2031
- Table 27 : North American Market for Organoids and Spheroids, by End User, Through 2031
- Table 28 : European Market for Organoids and Spheroids, by Country, Through 2031
- Table 29 : European Market for Organoids and Spheroids, by Product Type, Through 2031
- Table 30 : European Market for Organoids and Spheroids, by Application, Through 2031
- Table 31 : European Market for Organoids and Spheroids, by End User, Through 2031
- Table 32 : Asia-Pacific Market for Organoids and Spheroids, by Country, Through 2031
- Table 33 : Asia-Pacific Market for Organoids and Spheroids, by Product Type, Through 2031
- Table 34 : Asia-Pacific Market for Organoids and Spheroids, by Application, Through 2031
- Table 35 : Asia-Pacific Market for Organoids and Spheroids, by End User, Through 2031
- Table 36 : South American Market for Organoids and Spheroids, by Country, Through 2031
- Table 37 : South American Market for Organoids and Spheroids, by Product Type, Through 2031
- Table 38 : South American Market for Organoids and Spheroids, by Application, Through 2031
- Table 39 : South American Market for Organoids and Spheroids, by End User, Through 2031
- Table 40 : MEA Market for Organoids and Spheroids, by Subregion, Through 2031
- Table 41 : MEA Market for Organoids and Spheroids, by Product Type, Through 2031
- Table 42 : MEA Market for Organoids and Spheroids, by Application, Through 2031
- Table 43 : MEA Market for Organoids and Spheroids, by End User, Through 2031
- Table 44 : Leading Providers of Organoids and Spheroids, 2025
- Table 45 : Recent Developments in the Organoids and Spheroids Market, January 2024 to June 2026
- Table 46 : Abbreviations Used in This Report
- Table 47 : Bio-Techne: Company Snapshot
- Table 48 : Bio-Techne: Financial Performance, FY 2023 and 2024
- Table 49 : Bio-Techne: Product Portfolio
- Table 50 : Corning Inc.: Company Snapshot
- Table 51 : Corning Inc.: Financial Performance, FY 2024 and 2025
- Table 52 : Corning Inc.: Product Portfolio
- Table 53 : Corning Inc.: News/Key Developments, 2025
- Table 54 : Greiner Bio-One International GmbH: Company Snapshot
- Table 55 : Greiner Bio-One International GmbH: Product Portfolio
- Table 56 : InSphero: Company Snapshot
- Table 57 : InSphero: Product Portfolio
- Table 58 : InSphero: News/Key Developments, 2024-2026
- Table 59 : Lonza: Company Snapshot
- Table 60 : Lonza: Financial Performance, FY 2024 and 2025
- Table 61 : Lonza: Product Portfolio
- Table 62 : Merck KGaA: Company Snapshot
- Table 63 : Merck KGaA: Financial Performance, FY 2024 and 2025
- Table 64 : Merck KGaA: Product Portfolio
- Table 65 : Merck KGaA: News/Key Developments, 2025
- Table 66 : Molecular Devices LLC.: Company Snapshot
- Table 67 : Molecular Devices LLC.: Product Portfolio
- Table 68 : Revvity: Company Snapshot
- Table 69 : Revvity: Financial Performance, FY 2024 and 2025
- Table 70 : Revvity: Product Portfolio
- Table 71 : STEMCELL Technologies: Company Snapshot
- Table 72 : STEMCELL Technologies: Product Portfolio
- Table 73 : Thermo Fisher Scientific Inc.: Company Snapshot
- Table 74 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2024 and 2025
- Table 75 : Thermo Fisher Scientific Inc.: Product Portfolio
- Table 76 : List of a Few Emerging Startups/Market Disruptors
List of Figures
- Summary Figure : Global Market Shares for Organoids and Spheroids, by Region, 2025
- Figure 1 : Porter's Five Forces Analysis: Organoids and Spheroids Market
- Figure 2 : Market Dynamics of Organoids and Spheroids
- Figure 3 : Emerging Technologies in the Organoids and Spheroids Market
- Figure 4 : Total Number of Patents, by Year, 2024 and 2025
- Figure 5 : Global Market Shares for Organoids and Spheroids, by Product Type, 2025
- Figure 6 : Global Market Shares for Organoids, by Region, 2025
- Figure 7 : Global Market Shares for Organoids, by Type, 2025
- Figure 8 : Global Market Shares for Spheroids, by Region, 2025
- Figure 9 : Global Market Shares for Spheroids, by Type, 2025
- Figure 10 : Global Market Shares for Organoids and Spheroids, by Application, 2025
- Figure 11 : Global Market Shares for Organoids and Spheroids for Drug Discovery and Personalized Medicine, by Region, 2025
- Figure 12 : Global Market Shares for Organoids and Spheroids for Developmental Biology, by Region, 2025
- Figure 13 : Global Market Shares for Organoids and Spheroids for Disease Pathology Studies, by Region, 2025
- Figure 14 : Global Market Shares for Organoids and Spheroids for Drug Toxicity and Efficacy Testing, by Region, 2025
- Figure 15 : Global Market Shares for Organoids and Spheroids for Regenerative Medicine, by Region, 2025
- Figure 16 : Global Market Shares for Organoids and Spheroids, by End User, 2025
- Figure 17 : Global Market Shares for Organoids and Spheroids for Pharmaceutical and Biotechnology Companies, by Region, 2025
- Figure 18 : Global Market Shares for Organoids and Spheroids for Academic and Research Institutes, by Region, 2025
- Figure 19 : Global Market Shares for Organoids and Spheroids for Contract Research Organizations, by Region, 2025
- Figure 20 : Global Market Shares for Organoids and Spheroids for Hospitals and Diagnostic Centers, by Region, 2025
- Figure 21 : Global Market Shares for Organoids and Spheroids for Other End Users, by Region, 2025
- Figure 22 : Global Market Shares for Organoids and Spheroids, by Region, 2025
- Figure 23 : North American Market Shares for Organoids and Spheroids, by Country, 2025
- Figure 24 : European Market Shares for Organoids and Spheroids, by Country, 2025
- Figure 25 : Asia-Pacific Market Shares for Organoids and Spheroids, by Country, 2025
- Figure 26 : South American Market Shares for Organoids and Spheroids, by Country, 2025
- Figure 27 : MEA Market Shares for Organoids and Spheroids, by Subregion, 2025
- Figure 28 : Bio-Techne: Revenue Share, by Business Unit, FY 2024
- Figure 29 : Bio-Techne: Revenue Share, by Country/Region, FY 2024
- Figure 30 : Corning Inc.: Revenue Shares, by Business Unit, FY 2025
- Figure 31 : Corning Inc.: Revenue Shares, by Country/Region, FY 2025
- Figure 32 : Lonza: Revenue Shares, by Business Unit, FY 2025
- Figure 33 : Lonza: Revenue Shares, by Country/Region, FY 2025
- Figure 34 : Merck KGaA: Revenue Share, by Business Unit, FY 2025
- Figure 35 : Merck KGaA: Revenue Share, by Country/Region, FY 2025
- Figure 36 : Revvity: Revenue Shares, by Business Unit, FY 2025
- Figure 37 : Revvity: Revenue Shares, by Country/Region, FY 2025
- Figure 38 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2025
- Figure 39 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2025
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.